Tremedics
North Richland Hills, Texas, United States
About Tremedics
Tremedics develops bioresorbable technology for congenital heart disease patients with congenital heart disease need devices that resorb within their bodies as they grow. Their technology utilises a minimally invasive surgery procedure for stent delivery and permits vessel growth as the stent resorbs in the body.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Grant (Apr 2025)
- Website: tremedics.com
- Phone: (469) 708-6873
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tremedics-2571701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.